Viridian Therapeutics, Inc.
VRDN· Nasdaq
VRDNViridian Therapeutics, Inc.
Quarterly figures for Viridian Therapeutics, Inc., with source filings when available.
53 quarters. Jun 30, 2013 to Jun 30, 2026. USD.
Viridian Therapeutics, Inc. has filed its 10-Q within 35 to 43 days of period end across its last 8 quarters. The 10-K runs 57 to 85 days.
Viridian Therapeutics, Inc. · CIK 1590750 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $284.00K | +278.7% | — | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 5, 2026 · pre-market |
| May 5, 2026 |
| 35 d |
| 10-Q |
| $141.00K |
| +95.8% |
| — |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 26, 2026 · pre-market | Feb 26, 2026 | 57 d | 10-K | $132.00K | +83.3% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 5, 2025 · pre-market | Nov 5, 2025 | 36 d | 10-Q | $70.57M | +81,958.1% | — | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · pre-market | Aug 6, 2025 | 37 d | 10-Q | $75.00K | +4.2% | — | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · pre-market | May 6, 2025 | 36 d | 10-Q | $72.00K | ±0.0% | — | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 27, 2025 · pre-market | Mar 3, 2025 | 62 d | 10-K | $72.00K | ±0.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · pre-market | Nov 12, 2024 | 43 d | 10-Q | $86.00K | +19.4% | -$1.15 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | $72.00K | ±0.0% | -$1.02 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · pre-market | May 8, 2024 | 38 d | 10-Q | $72.00K | −26.5% | -$0.79 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 27, 2024 · after-hours | Feb 27, 2024 | 58 d | 10-K | $72.00K | −31.4% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | $72.00K | −94.0% | -$1.09 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 8, 2023 | 39 d | 10-Q | $72.00K | −71.9% | -$1.27 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 10, 2023 | 40 d | 10-Q | $98.00K | −54.6% | -$1.61 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 8, 2023 · pre-market | Mar 9, 2023 | 68 d | 10-K | $105.00K | −50.9% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | $1.20M | +474.5% | -$0.86 | |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 · pre-market | Aug 15, 2022 | 46 d | 10-Q | $256.00K | −76.5% | -$1.06 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · after-hours | May 13, 2022 | 43 d | 10-Q | $216.00K | −85.1% | -$0.98 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 10, 2022 · after-hours | Mar 11, 2022 | 70 d | 10-K | $214.00K | +296.3% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 5, 2021 | 36 d | 10-Q | $208.00K | — | -$1.25 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | $1.09M | +548.8% | -$2.21 | |
| Q1 2021 | Mar 31, 2021 | — | May 7, 2021 | 37 d | 10-Q | $1.45M | +75.2% | -$2.91 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 26, 2021 | 85 d | 10-K | $54.00K | −93.9% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 12, 2020 | 43 d | 10-Q | $0.00 | −100.0% | -$1.48 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 5, 2020 | 36 d | 10-Q | $168.00K | −93.3% | -$1.82 | |
| Q1 2020 | Mar 31, 2020 | — | May 8, 2020 | 38 d | 10-Q | $828.00K | +122.6% | -$2.65 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 13, 2020 | 73 d | 10-K | $880.00K | +84.9% | -$0.31 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 8, 2019 | 39 d | 10-Q | $695.00K | −26.4% | -$0.36 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 8, 2019 | 39 d | 10-Q | $2.51M | +15.2% | -$0.29 | |
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $372.00K | −92.2% | -$0.38 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Mar 14, 2019 | 73 d | 10-K | $476.00K | −60.1% | -$0.33 | |
| Q3 2018 | Sep 30, 2018 | — | Nov 7, 2018 | 38 d | 10-Q | $944.00K | −42.1% | -$0.29 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 8, 2018 | 39 d | 10-Q | $2.18M | +203.9% | -$0.29 | |
| Q1 2018 | Mar 31, 2018 | — | May 9, 2018 | 39 d | 10-Q | $4.78M | +935.5% | -$0.18 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 15, 2018 | 74 d | 10-K | $1.19M | +134.2% | -$0.29 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 9, 2017 | 40 d | 10-Q | $1.63M | +74.3% | -$0.27 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $718.00K | −66.0% | -$0.34 | |
| Q1 2017 | Mar 31, 2017 | — | May 11, 2017 | 41 d | 10-Q | $462.00K | −77.5% | -$0.60 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 24, 2017 | 83 d | 10-K | $509.00K | −68.1% | -$9.20 | |
| Q3 2016 | Sep 30, 2016 | — | Oct 26, 2016 | 26 d | 10-Q | $936.00K | −29.9% | -$6.92 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 15, 2016 | 46 d | 10-Q | $2.11M | +44.7% | -$5.88 | |
| Q1 2016 | Mar 31, 2016 | — | May 16, 2016 | 46 d | 10-Q | $2.05M | +55.7% | -$5.58 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 21, 2016 | 81 d | 10-K | $1.60M | +6.0% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $1.34M | −28.7% | -$0.39 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $1.46M | −10.1% | -$0.33 | |
| Q1 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | $1.32M | −11.3% | -$0.45 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 27, 2015 | 86 d | 10-K | $1.51M | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 14, 2014 | 45 d | 10-Q | $1.87M | +30.3% | -$0.40 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $1.62M | +30.8% | -$4.73 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $1.48M | — | -$3.53 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | — | — | — | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $1.44M | — | -$4.70 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $1.24M | — | -$3.15 | |
